Reasons to Engage with USC Stevens
Thriving Research Enterprise in a Vibrant Innovation Ecosystem
USC is one of the world’s leading private research universities with more than $909 million in annual research expenditures in 2019. The university is ideally situated in the heart of a diverse, vibrant, innovative region.
Solution Oriented, Win-Win Approach
We bring an innovative mindset to deepening and strengthening our relationships with industry partners and take a solution-oriented, win-win approach to our interactions.
Experienced, Insightful Team of Technology Licensing Pros
Our senior management team has extensive experience in both the private sector and academic/research institutions. They lead a talented team with broad expertise across a number of disciplines.
Featured Technologies
USC-led innovation and its ongoing impact
USC is one of the nation’s leading institutions for innovative discovery. Leading this effort is Dr. Ishwar Puri, who discusses its impact.
USC discovery shows long-term viability of stem cell derived retinal implant
Newly published data from USC has shown a stem-cell derived implant designed to improve vision for patients suffering from age-related macular degeneration can safely be inserted into the eye and without the need for long-term immunosuppressants.
Year in Review: 2021 USC research discoveries
Take a look at some of the most memorable research stories in 2021 about discoveries made by USC researchers.
Success Stories
AI tool based on Shri Narayanan’s research adopted by NBCUniversal
Spellcheck for Bias is a digital tool developed by the Geena Davis Institute in partnership with the Signal Analysis and Interpretation Laboratory at USC’s Viterbi School of Engineering.
USC and other leading universities launch joint technology licensing program
USC has joined a coalition of 15 leading research universities that aims to boost the transfer of researchers’ patented technologies and inventions to companies.
Next-generation liquid biopsy technology licensed to Epic Sciences
Epic Sciences and USC Michelson Center Convergent Science Institute in Cancer recently announced a new partnership. The Stevens Center helped Dr. Peter Kuhn with the process of executing the license and collaboration agreement.